phlebotomy training nj phlebotomy courses in ny phlebotomy courses in chicago
Tuesday, 10 April 2012
Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
CLEVELAND, April 6, 2012 (HSMN NewsFeed) -- Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical tria... Devices, Orthopaedic, FDAArteriocyte, Magellan MAR01, Compartment Syndrome (Source: HSMN NewsFeed)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment